AIM • KMU EXAM PRACTICE

Question:

A 64-year-old man with long-standing chronic bladder irritation develops persistent hematuria. Histology of a bladder mass shows malignant keratinizing squamous cells rather than urothelial differentiation. Which tumor classification best fits this finding?

Options:

Correct Answer: Squamous cell carcinoma

Explanation: Keratinizing malignant squamous cells identify squamous carcinoma, a bladder tumor associated with chronic irritation and squamous metaplasia rather than the usual urothelial pathway.

Question:

Cystoscopy in a patient with hematuria shows an irregular, firm, ulcerated bladder lesion producing focal thickening of the wall rather than delicate fronds. Which pathological behavior is most consistent with this gross appearance?

Options:

Correct Answer: Infiltrative urothelial carcinoma

Explanation: A firm, ulcerated and wall-thickening lesion suggests infiltrative growth rather than a superficial papillary pattern, raising concern for invasive urothelial carcinoma.

Question:

A papillary bladder tumor is removed endoscopically. Histology shows a papillary lesion confined above the basement membrane without invasion of lamina propria. Which local stage best describes this lesion?

Options:

Correct Answer: Ta

Explanation: Ta represents non-invasive papillary urothelial carcinoma; invasion into lamina propria would change the stage to T1.

Question:

A patient with bladder carcinoma has imaging evidence of direct invasion into an adjacent pelvic organ. There is no distant metastasis. Which local tumor category best describes this extent?

Options:

Correct Answer: T4

Explanation: T4 bladder carcinoma has progressed beyond perivesical tissue to invade adjacent structures or the pelvic/abdominal wall.

Question:

A fit patient has muscle-invasive bladder carcinoma but wishes to discuss an organ-preserving approach. Which treatment principle can provide bladder preservation in appropriately selected patients?

Options:

Correct Answer: Maximal endoscopic resection with chemoradiation

Explanation: Selected patients with muscle-invasive bladder cancer may undergo a bladder-preserving strategy combining maximal TURBT with chemotherapy and radiotherapy.

Question:

A 67-year-old man undergoes definitive treatment planning for muscle-invasive bladder carcinoma. Imaging shows no distant metastasis, but the multidisciplinary team recommends systemic therapy because microscopic disease may already exist beyond the bladder. Which drug approach best reflects this principle?

Options:

Correct Answer: Platinum-based systemic chemotherapy

Explanation: Muscle-invasive urothelial cancer carries a risk of occult systemic spread, so platinum-based systemic chemotherapy may be incorporated with definitive local treatment.

Question:

A patient with disseminated bladder carcinoma develops troublesome tumor-related hematuria and pelvic pain despite systemic disease being unsuitable for curative local surgery. Which management principle is most appropriate?

Options:

Correct Answer: Use local treatment for symptom palliation when appropriate

Explanation: Even when metastatic bladder cancer is not curable locally, radiotherapy or procedures may still be used to control bleeding, obstruction or pain.

Question:

A man whose father and brother were both treated for prostate carcinoma asks why his risk is considered increased. Which underlying factor best explains this clinical concern?

Options:

Correct Answer: Inherited susceptibility to malignant transformation

Explanation: A strong family history can reflect inherited cancer-predisposition abnormalities, increasing susceptibility to prostate epithelial malignant transformation.

Question:

Prostate carcinoma cells in an advanced tumor remain strongly dependent on androgen-receptor signaling. Which consequence of this biological feature most directly influences treatment selection?

Options:

Correct Answer: Reduction of androgen signaling can suppress tumor growth

Explanation: Dependence on the androgen receptor provides a therapeutic target; reducing androgen production or receptor signaling decreases androgen-dependent growth signals.

Question:

A prostate carcinoma is palpable on examination but remains confined within the gland on assessment, with no extraprostatic extension. Which local T category best corresponds to this finding?

Options:

Correct Answer: T2

Explanation: T2 prostate cancer is clinically apparent but remains confined to the prostate; extension outside the gland moves the tumor into higher T categories.

Question:

A man with confirmed prostate adenocarcinoma has a tumor fixed to surrounding structures beyond the expected extent of seminal-vesicle involvement. Which stage best represents this local disease?

Options:

Correct Answer: T4

Explanation: T4 prostate carcinoma is fixed or invades adjacent structures beyond the usual extraprostatic or seminal-vesicle extension classified as T3.

Question:

A patient has clinical suspicion of prostate carcinoma. Before tissue sampling, an imaging study is requested to identify a suspicious intraprostatic lesion and assess local extent. Which investigation best serves this role?

Options:

Correct Answer: Multiparametric MRI of the prostate

Explanation: Multiparametric MRI helps localize suspicious prostate lesions, assess local extent and guide targeted biopsy decisions.

Question:

A 62-year-old man with localized prostate carcinoma is medically fit but prefers definitive non-surgical local therapy after discussing curative options. Which treatment principle best matches his preference?

Options:

Correct Answer: Radiotherapy directed at the localized tumor

Explanation: Radiotherapy is a major definitive local treatment option for appropriately selected localized prostate carcinoma when surgery is not chosen.

Question:

A clinician wants pharmacological suppression of testicular testosterone without the initial stimulatory phase produced by continuous GnRH agonist therapy. Which pharmacological strategy best achieves this?

Options:

Correct Answer: Use a GnRH-receptor antagonist

Explanation: GnRH antagonists directly block pituitary receptors, rapidly lowering LH and testosterone without an initial stimulatory testosterone surge.

Question:

A man with advanced prostate cancer is treated with an agent that blocks androgen receptors and also reduces gonadotropin secretion through progestational activity. Which drug has this dual action?

Options:

Correct Answer: Cyproterone acetate

Explanation: Cyproterone is a steroidal anti-androgen that antagonizes the androgen receptor and also suppresses gonadotropins through progestational activity.

Question:

A patient receiving taxane chemotherapy for advanced prostate carcinoma develops tingling and numbness in both feet while the tumor remains under treatment. Which adverse effect best accounts for these symptoms?

Options:

Correct Answer: Peripheral neuropathy

Explanation: Taxanes can injure peripheral nerves as well as suppress bone marrow, so distal sensory symptoms during therapy suggest peripheral neuropathy.

Question:

A patient with metastatic prostate carcinoma progresses after treatment with one taxane. The oncology team considers another drug from the same class that can be used in selected advanced disease after progression. Which agent fits this description?

Options:

Correct Answer: Cabazitaxel

Explanation: Cabazitaxel is a taxane used in selected advanced prostate carcinoma, particularly after progression in appropriate previously treated patients.

Question:

A man receiving long-term androgen-deprivation therapy remains clinically stable but develops progressive loss of bone and muscle mass. Which mechanism best explains these treatment-related changes?

Options:

Correct Answer: Loss of normal androgen effects on bone and muscle

Explanation: Sustained androgen suppression reduces normal anabolic effects on skeletal muscle and bone, contributing to muscle loss and reduced bone mass.

Question:

A patient with metastatic prostate carcinoma is taking an androgen-receptor blocker. Laboratory monitoring subsequently shows marked elevation of hepatic enzymes. Which management consideration is most directly related to this drug class?

Options:

Correct Answer: Recognize possible clinically important hepatic toxicity

Explanation: Anti-androgens such as flutamide and cyproterone acetate can produce important hepatic toxicity, so abnormal liver tests require clinical attention.

Question:

Two patients have newly diagnosed malignancies. One has a bladder tumor invading muscle, while the other has prostate carcinoma still confined to the gland. Which principle best explains why their management pathways differ despite both having urological cancer?

Options:

Correct Answer: Stage and tumor biology determine the appropriate treatment strategy

Explanation: Muscle invasion fundamentally changes bladder-cancer management, while localized prostate carcinoma may still be treated with local curative strategies; stage and biology drive treatment decisions.